Clinical Trial of Fluid Infusion Rates for Pediatric Diabetic Ketoacidosis.
Nathan KuppermannSimona GhettiJeff E SchunkMichael J StonerArleta RewersJulie K McManemySage R MyersLise E NigrovicAris GarroKathleen M BrownKimberly S QuayleJennifer L TrainorLeah TzimenatosJonathan E BennettAndrew D DePieroMaria Y KwokClinton S PerryCody S OlsenT Charles CasperJ Michael DeanNicole S Glasernull nullPublished in: The New England journal of medicine (2018)
Neither the rate of administration nor the sodium chloride content of intravenous fluids significantly influenced neurologic outcomes in children with diabetic ketoacidosis. (Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the Health Resources and Services Administration; PECARN DKA FLUID ClinicalTrials.gov number, NCT00629707 .).
Keyphrases
- clinical trial
- healthcare
- type diabetes
- endothelial cells
- wound healing
- mental health
- public health
- young adults
- primary care
- low dose
- quality improvement
- induced pluripotent stem cells
- health information
- pluripotent stem cells
- phase ii
- open label
- study protocol
- randomized controlled trial
- metabolic syndrome
- risk assessment
- health promotion
- glycemic control
- health insurance
- insulin resistance
- social media